Dollars for Profs

Dig Into University Researchers' Outside Income and Conflicts of Interest

Published Dec. 6, 2019

This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.

Financial doc
Filing Type

Conflict of Interest

Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.

Should you be removed from our database? Contact us at [email protected]. Read more below.

Ning Jiang

University of Texas, Austin, Department: Biomedical Engineering

Should you be removed from our database? Contact us at [email protected]. Read more below.

Disclosed Conflict of Interest with

ImmuDX, LLC

Disclosed Value
Listed Reason
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)

The CI's spouse is founder and CEO of ImmuDX, LLC and holds primary equity ownership in the company. ImmuDX, LLC is involved in the development and commercialization of technologies related to immune repertoire sequencing and high-throughput immune analysis and engineering for clinical and research purposes. The CI serves as Scientific Advisor for the company. ImmuDX, LLC may license technologies that were developed by the CI through her work at the University. The business interests of the company overlap with the CI's research.

Listed Research Project
An integrated approach to T cell repertoire in aging

Narrative Aging and CMV infection correlate with a dysfunctional or inadequate immune response. With the population in the US and other industrialized countries shifting towards a greater fraction of older people, this becomes an ever more urgent issue. Data generated from this study will help us understand how aging and CMV infection impact the CD8+ T cell repertoire, which will provide scientific evidence in policy making regarding CMV vaccine development and immunization.

Filed on July 18, 2019.

Tell us what you know about Ning Jiang's disclosure

We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?

Name Institution Type Company Disclosed Value
Ning Jiang University of Texas, Austin Conflict of Interest Immune Arch, Inc. Value cannot be readily determined
Ning Jiang University of Texas, Austin Conflict of Interest Immune Arch, Inc. Value cannot be readily determined
Ning Jiang University of Texas, Austin Conflict of Interest ImmuDX, LLC Value cannot be readily determined
Name Institution Type Company Disclosed Value
Ning Jiang University of Texas, Austin Financial Disclosure Zhongyuan Union Genetic Technology Co.,Ltd
Ning Jiang University of Texas, Austin Financial Disclosure ImmuDX, LLC
Ning Jiang University of Texas, Austin Financial Disclosure ImmuDX, LLC
If you see an error in the database or a reason we should not disclose a record, please contact us at [email protected] and we'll evaluate it on a case-by-case basis.
Sources: National Institutes of Health, public records requests filed at multiple public state universities

Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.

Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.

ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.

Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print RSS Search Search Twitter WhatsApp
Current site Current page